<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="review-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1187638</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2023.1187638</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>
<italic>Helicobacter pylori</italic> regulates stomach diseases by activating cell pathways and DNA methylation of host cells</article-title>
<alt-title alt-title-type="left-running-head">Xi et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcell.2023.1187638">10.3389/fcell.2023.1187638</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Xi</surname>
<given-names>Yue</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2247207/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Xiao-Li</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luo</surname>
<given-names>Qing-Xin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gan</surname>
<given-names>Hai-Ning</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Yu-Shi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Shao</surname>
<given-names>Shi-He</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1412075/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Mao</surname>
<given-names>Xu-Hua</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>School of Medicine</institution>, <institution>Jiangsu University</institution>, <addr-line>Zhenjiang</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Clinical Laboratory</institution>, <institution>The Affiliated Yixing Hospital of Jiangsu University</institution>, <addr-line>Wuxi</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1090239/overview">Xingxing Jian</ext-link>, Central South University, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2280260/overview">Daqing Gao</ext-link>, Southeast University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2283799/overview">Haidun Yan</ext-link>, Duke University, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Shi-He Shao, <email>shaoshihe2006@163.com</email>; Xu-Hua Mao, <email>staff1291@yxph.com</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors share first authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>05</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>11</volume>
<elocation-id>1187638</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>03</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>04</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Xi, Zhang, Luo, Gan, Liu, Shao and Mao.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Xi, Zhang, Luo, Gan, Liu, Shao and Mao</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>One of the most prevalent malignant tumors of the digestive tract is gastric cancer (GC). Age, high salt intake, <italic>Helicobacter pylori</italic> (<italic>H. pylori</italic>) infection, and a diet deficient in fruits and vegetables are risk factors for the illness. A significant risk factor for gastric cancer is infection with <italic>H. pylori</italic>. Infecting gastric epithelial cells with virulence agents secreted by <italic>H. pylori</italic> can cause methylation of tumor genes or carcinogenic signaling pathways to be activated. Regulate downstream genes&#x2019; aberrant expression, albeit the precise mechanism by which this happens is unclear. Oncogene, oncosuppressor, and other gene modifications, as well as a number of different gene change types, are all directly associated to the carcinogenesis of gastric cancer. In this review, we describe comprehensive <italic>H. pylori</italic> and its virulence factors, as well as the activation of the NF-&#x3ba;B, MAPK, JAK/STAT signaling pathways, and DNA methylation following infection with host cells via virulence factors, resulting in abnormal gene expression. As a result, host-related proteins are regulated, and gastric cancer progression is influenced. This review provides insight into the <italic>H. pylori</italic> infection, summarizes a series of relevant papers, discusses the complex signaling pathways underlying molecular mechanisms, and proposes new approach to immunotherapy of this important disease.</p>
</abstract>
<kwd-group>
<kwd>
<italic>Helicobacter pylori</italic>
</kwd>
<kwd>signaling pathway</kwd>
<kwd>apoptosis</kwd>
<kwd>DNA methylation</kwd>
<kwd>gastric cancer</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Epigenomics and Epigenetics</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>The third most common cause of cancer-related death worldwide, gastric cancer (GC) is one of the most prevalent malignant tumors. The prevalence of GC varies greatly among various geographical areas (<xref ref-type="bibr" rid="B51">Machlowska et al., 2020</xref>; <xref ref-type="bibr" rid="B72">Petryszyn et al., 2020</xref>). Its growth and evolution are multi-year, multi-stage processes that continue to be a problem for global health today (<xref ref-type="bibr" rid="B26">Gao et al., 2018</xref>).</p>
<p>The most significant risk factor for GC is <italic>Helicobacter pylori</italic> (<italic>H. pylori</italic>), which is one of the most prevalent infectious organisms in humans globally (<xref ref-type="bibr" rid="B64">Noto and Peek, 2012</xref>). <italic>H. pylori</italic> is categorized by the World Health Organization (WHO) as a class 1 carcinogen (<xref ref-type="bibr" rid="B21">Crowe, 2019</xref>). Numerous virulence factors produced by <italic>H. pylori</italic> have the potential to disrupt intracellular signaling pathways in the host and lower the threshold for tumor transformation. In addition, gastric cancer, the <italic>H. pylori</italic> infection can also cause other stomach diseases, including gastric ulcer, duodenal ulcer, stomach atrophy and other diseases. The <italic>H. pylori</italic> infection is strongly associated with major gastritis and multifocal atrophy, and testing for <italic>H. pylori</italic> is another important component of screening for these diseases.</p>
<p>The main pathogenic agents in the <italic>H. pylori</italic> infection are CagA (cytotoxin-related gene A), its pathogenicity island (Cag PAI), and VacA (vacuolar cytotoxin A) (<xref ref-type="bibr" rid="B102">Wang F et al., 2014</xref>). The CagA protein and the Cag IV secretion system (T4SS) are encoded by 27&#x2013;31 genes in the 40&#xa0;kb Cag PAI DNA insertion element (<xref ref-type="bibr" rid="B61">Muller, 2012</xref>; <xref ref-type="bibr" rid="B4">Backert et al., 2015</xref>). The three proteins CagL, CagI, and CagH are parts of the T4SS subcomponents and are all necessary for Cag T4SS, which may be crucial in the development of the infectious contact between <italic>H. pylori</italic> and stomach epithelial cells. Through bacteria and epithelial cells, CagA T4SS transports CagA from connected <italic>H. pylori</italic> into host cells, through the passage of bacterial and epithelial membranes, CagA T4SS carries CagA from the associated into the host cells (<xref ref-type="bibr" rid="B65">Odenbreit et al., 2000</xref>; <xref ref-type="bibr" rid="B25">Fischer et al., 2001</xref>; <xref ref-type="bibr" rid="B87">Shaffer et al., 2011</xref>). It binds to the inside of cell membranes, causing the downstream signaling pathways to be activated by tyrosine phosphorylation at the N-terminal glutamate-proline-isoleucine-tyrosine-alanine (EPIYA) site (<xref ref-type="bibr" rid="B104">Wroblewski and Peek, 2016</xref>). Vacuolar cytotoxin A (VacA), an 88&#xa0;kDa protein made up of the p33 and p55 protein subunits, can be secreted using the IV-type autotransporter and secretion system. This protein alters a number of things, including the permeability of the mitochondrial membrane, the vacuolation of host gastric epithelial cells, autophagy, apoptosis, and disruption of epithelial tight junctions. Additionally, it prevents lamina propria T lymphocyte activation and proliferation (<xref ref-type="bibr" rid="B20">Cover and Blanke, 2005</xref>; <xref ref-type="bibr" rid="B67">Palframan et al., 2012</xref>; <xref ref-type="bibr" rid="B80">Raju et al., 2012</xref>).</p>
<p>The release of virulence factors following the <italic>H. pylori</italic> infection of gastric epithelial cells can activate downstream signaling pathways and associated processes, including the nuclear factor &#x3ba;B (NF-&#x3ba;B) pathway and the cytokine-stimulated transduction (JAK-STAT) signaling system. Furthermore, these virulence factors have the ability to induce apoptosis and methylation of the relevant proteins, which can control the expression of a number of host proteins and influence the appearance and growth of GC.</p>
</sec>
<sec id="s2">
<title>
<italic>Helicobacter pylori</italic> infected host cells activate NF-&#x3ba;B signaling pathway</title>
<p>Gastric epithelial cells were colonized by <italic>H. pylori</italic>, which then activated the natural and NF-&#x3ba;B pathway (<xref ref-type="bibr" rid="B55">Maubach et al., 2021</xref>; <xref ref-type="bibr" rid="B56">Maubach et al., 2022</xref>). Inflammation is brought on by <italic>H. pylori</italic> CagA stimulating the NF-&#x3ba;B pathway and binding TAK1 to TRAFs, which in turn activates the I&#x3ba;B kinase (IKK) comple<italic>x</italic> (<xref ref-type="bibr" rid="B8">Brandt et al., 2005</xref>; <xref ref-type="bibr" rid="B113">Zhang et al., 2019</xref>). Protein modification and intracellular location control the formation of homologous dimers and heterodimers that both activate and inhibit transcription (<xref ref-type="bibr" rid="B62">Neumann and Naumann, 2007</xref>), the NF-&#x3ba;B family of transcription factors regulates immunological response, inflammatory response (<xref ref-type="bibr" rid="B33">Hayden and Ghosh, 2011</xref>), cell proliferation, differentiation, and genomic stability (<xref ref-type="bibr" rid="B49">Liu et al., 2017</xref>; <xref ref-type="bibr" rid="B69">Peng et al., 2020</xref>).</p>
<p>Following the <italic>H. pylori</italic> infection, GC cells secreted more IL-8 and IL-32. For the IL-8 gene to be transcribed, the essential transcription factor NF-&#x3ba;B must be activated by binding to either AP-1 or NF-IL6 (<xref ref-type="bibr" rid="B108">Yasumoto et al., 1992</xref>), in GC cells, AP-1 may take the place of NF-IL6 and work in conjunction with NF-&#x3ba;B to cause IL-8 gene transcription binding to form a complex (<xref ref-type="bibr" rid="B2">Aihara et al., 1997</xref>). Additionally, NF-&#x3ba;B increases the expression of the inflammatory cytokine IL-32, which in turn increases the expression of NF-&#x3ba;B. This occurs mostly through the CAG pathogenicity island (cagPAI)-positive (<xref ref-type="bibr" rid="B85">Sakitani et al., 2012</xref>). A crucial metalloproteinase is MMP-7, in a CAG pathogenicity island (cagPAI) -dependent way, causes a persistent inflammatory response and increases gastrin expression in gastric epithelial cells. Gastrin increases MMP-7 via triggering the NF-&#x3ba;B signaling pathway via the protein kinase C-dependent pathway linked to I&#x3ba;B kinase. Additionally, it stimulates the expression of the HB-EGF gene for epidermal growth factor and ectodomain shedding. (<xref ref-type="bibr" rid="B6">Bebb et al., 2003</xref>; <xref ref-type="bibr" rid="B66">Ogasa et al., 2003</xref>; <xref ref-type="bibr" rid="B22">Dickson et al., 2006</xref>; <xref ref-type="bibr" rid="B110">Yin et al., 2010</xref>). Additionally, a the <italic>H. pylori</italic> infection of the stomach causes the release of MMP-9, a matrix metalloproteinase (<xref ref-type="bibr" rid="B34">Hojo et al., 2000</xref>; <xref ref-type="bibr" rid="B28">G&#xf6;&#xf5;z et al., 2001</xref>), the intracellular kinases NIK and IKKs stimulate the NF-&#x3ba;B signaling pathway in gastric epithelial cells infected with cagPAI-positive <italic>H. pylori</italic>, controlling the production of MMP-9 (<xref ref-type="bibr" rid="B52">Maeda et al., 2000</xref>; <xref ref-type="bibr" rid="B58">Mori et al., 2003</xref>). The virulence factor urease and the effects of <italic>H. pylori</italic> on the expression and transcription levels of MUC in MUC genes (MUC5AC, MUC2, and MUC6) in gastric mucosa of Kato-III may upregulate the expression of chemokines and proinflammatory factors while downregulating the transcription of the MUC5AC gene in GC cells. On the other hand, the MUC5AC promoter has a &#x3ba;B cis-element, which reduces the activity of the promoter and lowers expression (<xref ref-type="bibr" rid="B70">Perrais et al., 2014</xref>). MUC1 is essential for controlling how negatively NLRP3 inflammasome activation affects immune cells. MUC1 expression rises following the <italic>H. pylori</italic> infection, which prevents NLRP3 from being activated by blocking the TLR/NF-&#x3ba;B-dependent signaling pathway. This, in turn, prevents the inflammatory response brought on by chronic the <italic>H. pylori</italic> infection (<xref ref-type="bibr" rid="B63">Ng et al., 2016</xref>; <xref ref-type="bibr" rid="B114">Zhang et al., 2022a</xref>).</p>
<p>One of the primary proteins regulating apoptosis is inhibitor of apoptosis protein (IAP), and cIAP2 (inhibitor of Apoptosis protein 2) is crucial for the development of cancer (<xref ref-type="bibr" rid="B14">Chen et al., 2020</xref>). The advancement of AG/IM and the <italic>H. pylori</italic> infection are not the only conditions that are linked to the overexpression of cIAP2 in GC, the primary mechanism is that <italic>H. pylori</italic> upregulates the expression of cIAP2 by activating the NF-&#x3ba;B signaling pathway in a cagPAI dependent manner (<xref ref-type="bibr" rid="B111">Yoon et al., 2017</xref>). A homolog of HP0305 called JHP0290 can attach to different cell types and alter macrophage reactions (<xref ref-type="bibr" rid="B68">Pathak et al., 2013</xref>). Different <italic>H. pylori</italic> strains can express and release the JHP0290 homolog. NF-&#x3ba;B activation was seen in gastric epithelial cells that had been stimulated by JHP0290, which considerably increased the amount of alkaline phosphatase (SEAP) activity in GC cells in a dose-dependent manner and activated the NF-&#x3ba;B signaling pathway, which controls a number of cellular processes in cancer (<xref ref-type="bibr" rid="B97">Tavares and Pathak, 2015</xref>). Additionally, <italic>H. pylori</italic> stimulates the LIGHT pathway, a distinct group of receptors in the tumor necrosis factor superfamily, in addition to the canonical NF-&#x3ba;B signaling pathway, which necessitates functional T4SS (TNFSF). The main mechanism is that the CAG pathogenicity island (cagPAI), after infecting gastric epithelial cells with <italic>H. pylori</italic>, stimulates ligand binding to the LT&#x3b2;R produced by epithelial cells and draws in immune cells to increase chemokines and suppress the usual NF-&#x3ba;B signaling pathway. There is a close connection between the common and alternate pathways during the <italic>H. pylori</italic> infection (<xref ref-type="bibr" rid="B57">Mejias-Luque et al., 2017</xref>). The expression of CAMKII (Ca21/calmodulin dependent kinase II) is regulated by calmodulin, the IKK complex is activated by CAMKII and calmodulin, which triggers the NF-&#x3ba;B signaling pathway (<xref ref-type="bibr" rid="B54">Maubach et al., 2013</xref>). Additionally, after the <italic>H. pylori</italic> infection, several medical substances can help control how proteins are expressed. Tanshinone IIA can effectively inhibit the activation of the NF-&#x3ba;B signaling pathway, destroying the production of downstream inflammatory substances and effectively reducing the inflammatory response induced by <italic>H. pylori</italic>. After the <italic>H. pylori</italic> infection, the expression of nuclear NF-&#x3ba;B (p65) protein increases significantly (<xref ref-type="bibr" rid="B12">Chen et al., 2016</xref>) (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>After the <italic>Helicobacter pylori</italic> infection, CagA is transferred from the attached <italic>H. pylori</italic> through the bacteria and epithelial cells to the host cell through the CagA-T4SS secretion system, which activates the expression of intracellular kinases NIK and gastrin as well as the homologues of JHP0290, and activates the activities of downstream intracellular kinases IKKs, PKC and SEAP, activate the NF-&#x3ba;B signaling pathway to regulate the expression of inflammatory cytokines IL-8 and IL-32, MMP7 and MMP9, and apoptosis inhibitor protein 2 (cIAP2). CAMKII and calmodulin can activate IKK complex and induce NF-&#x3ba;B signal. After the <italic>H. pylori</italic> infection, MUC5AC could bind to &#x3ba;B cil-element promoter, which caused decreases of MUC5AC promoter&#x2019;s activity and expression of MUC5AC. The release of Tanshinone IIA after the <italic>H. pylori</italic> infection can effectively inhibit the expression of NF-&#x3ba;B nuclear protein and inhibit the inflammatory signal.</p>
</caption>
<graphic xlink:href="fcell-11-1187638-g001.tif"/>
</fig>
</sec>
<sec id="s3">
<title>
<italic>Helicobacter pylori</italic> infected host cells activate ERK/MAPK signaling pathway</title>
<p>The MAPK signaling pathway can be activated by <italic>H. pylori</italic>-induced gastric epithelial cell growth and gene expression (<xref ref-type="bibr" rid="B86">Sebkova et al., 2004</xref>; <xref ref-type="bibr" rid="B116">Zhu et al., 2005</xref>; <xref ref-type="bibr" rid="B23">Ding et al., 2008</xref>). The mitogen-activated protein kinase (MAPK) family, which participates in signaling cascades and transmits extracellular signals to intracellular destinations, includes extracellular signal-regulated kinase 1/2 (ERK). In eukaryotic cells: ERK, JNK/stress-activated protein kinase, P38 MAPK, and ERK5 signal transduction pathways have all been found (<xref ref-type="bibr" rid="B31">Guo et al., 2020b</xref>). The extracellular signal-regulated protein kinase (ERK) cascade, which is typically controlled by the activation of cell-surface receptor tyrosine kinases (RTKS), is the most prevalent of these (<xref ref-type="bibr" rid="B39">Katz et al., 2007</xref>). A fundamental signal transduction system known as the MAPK signaling pathway controls cell growth, differentiation, and stress response (<xref ref-type="bibr" rid="B75">Plotnikov et al., 2011</xref>; <xref ref-type="bibr" rid="B84">Sabio and Davis, 2014</xref>; <xref ref-type="bibr" rid="B31">Guo et al., 2020b</xref>).</p>
<p>AUF1 is upregulated when <italic>H. pylori</italic> is present as a result of CagA-induced ERK pathway activation. GKN1 mRNA, a gastric tumor suppressor, can have its stability controlled by the ARE-binding protein AUF1. In light of this, it is possible that the CagA/p-ERK/AUF1 axis is crucial in the downregulation of the downstream AUF1 effector GKN1mRNA. Making it a GC oncogene (<xref ref-type="bibr" rid="B30">Guo et al., 2020a</xref>). Through the NF-&#x3ba;B signaling pathway, <italic>H. pylori</italic> can cause the expression of metalloproteinases, and through the ERK signaling pathway, it can control the expression of metalloproteinases. The <italic>H. pylori</italic> CAG pathogenicity island (cagPAI), which is implicated in GC metastasis, induces the ERK1/2 signaling pathway, which is responsible for the upregulation of MMP-1 production in gastric epithelial cells (<xref ref-type="bibr" rid="B43">Krueger et al., 2006</xref>; <xref ref-type="bibr" rid="B35">Jiang et al., 2014</xref>). The ERK1/2 signaling pathway activated by <italic>H. pylori</italic> also controls MMP-10. The CAGA-positive <italic>H. pylori</italic> strain damages the stomach epithelium by prompting gastric epithelial cells to produce and secrete active MMP-10 in GC cells, which in turn activates the tyrosine kinase receptor EGFR (<xref ref-type="bibr" rid="B18">Costa et al., 2016</xref>). Additionally, the MMP-10 expression caused by <italic>H. pylori</italic> was reduced by the red-orange pigment &#x3b2;-carotene, which <italic>in vivo</italic> can be converted to retinaldehyde, mostly by activating PPAR-&#x3b3; and triggering its downstream target catalase. As a result, <italic>H. pylori</italic>-infected gastric epithelial cells have lower levels of ROS and the ERK signaling pathway, as well as lower levels of MMP-10 expression and <italic>H. pylori</italic>-associated GC incidence (<xref ref-type="bibr" rid="B18">Costa et al., 2016</xref>; <xref ref-type="bibr" rid="B5">Bae et al., 2021</xref>).</p>
<p>The alteration in cell behavior brought on by <italic>H. pylori</italic> is mediated by AQP3. The expression of AQP3 in gastric cells is primarily controlled by the ERK signaling pathway, and reduction of AQP3 can inhibit the proliferation and migration of cancer cells generated by <italic>H. pylori</italic>. An essential membrane protein called Cxs controls the creation of intercellular channels, the interchange of signaling chemicals, and intercellular communication. Additionally, it plays a crucial role in intercellular communication (<xref ref-type="bibr" rid="B99">Vinken et al., 2006</xref>; <xref ref-type="bibr" rid="B27">Gemel et al., 2014</xref>). The virulence factor of <italic>H. pylori</italic>, the fact that VacA has no effect on the membrane protein Cx43&#x2019;s mRNA level raises the possibility that VacA might promote Cx43 accumulation by preventing Cx43 degradation. The amount of GSH that is turned over in GC&#xa0;cells may be controlled by VacA released by <italic>H. pylori</italic> (<xref ref-type="bibr" rid="B41">Kimura et al., 2001</xref>); the GSH levels influence the ROS-dependent ERK signaling pathway&#x2019;s activity, which controls the generation of Cx43 and apoptosis (<xref ref-type="bibr" rid="B107">Yahiro et al., 2015</xref>). Furthermore, <italic>H. pylori</italic> JHP0290 protein can not only activate the NF-&#x3ba;B pathway to participate in the inflammatory response, but also activate ERK MAPK in a dose-dependent manner to regulate the proliferation of gastric epithelial cells (<xref ref-type="bibr" rid="B97">Tavares and Pathak, 2015</xref>) (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>After the <italic>H. pylori</italic> infection, virulence factors are secreted into cells through the CagA-T4SS secretion system, activation of ROS and Ras/Raf/MEK proteins, activation of downstream ERK/MAPK signaling pathway, upregulate of AUF1 and control of GKN1 expression, ERK also control the expression of metal proteinases MMP1 and MMP10. &#x3b2;-carotene inhibits <italic>H. pylori</italic> induced the expression of MMP10, and the <italic>H. pylori</italic> virulence factor can upregulate Cx43 expression, and then activate the ROS-dependent ERK signaling pathway to reverse control Cx43 production and apoptosis. AQP3 is involved in the changes of cell behavior induced by <italic>H. pylori</italic> through the regulation of ERK pathway. JHP0290 released by <italic>H. pylori</italic> protein can activate the ERK pathway and regulate the proliferation of gastric epithelial cells.</p>
</caption>
<graphic xlink:href="fcell-11-1187638-g002.tif"/>
</fig>
</sec>
<sec id="s4">
<title>
<italic>Helicobacter pylori</italic> infected host cells activate JAK/STAT signaling pathway</title>
<p>Through the JAK/STAT signaling system, the <italic>H. pylori</italic> infection of gastric epithelial cells can control cell growth and the production of associated proteins. An essential signal transduction system is the JAK/STAT (Janus kinase/Signal Converter and Activator of transcription) cascade (<xref ref-type="bibr" rid="B40">Khanna et al., 2015</xref>). To control the expression of the associated genes, JAK phosphorylates STAT, which dimerizes and travels to the nucleus through the nuclear envelope (<xref ref-type="bibr" rid="B106">Xin et al., 2020</xref>). A family of non-transmembrane tyrosine kinases is known as the JAK family. The JAK clan is Most members of the JAK family are JAK1, JAK2, JAK3, and Tyk2 (<xref ref-type="bibr" rid="B9">Cai et al., 2015</xref>). One of the most important activating transcription factors in the immune response is the STAT family, which is a downstream target of JAKs in the cytoplasm. There are seven people who make up the group: STAT1, STAT2, STAT3, STAT4, STAT5A, STAT5B, and STAT6 (<xref ref-type="bibr" rid="B7">Boengler et al., 2008</xref>; <xref ref-type="bibr" rid="B112">Yu et al., 2009</xref>), cell proliferation, stem cell self-renewal, and immunological responses are only a few examples of the physiological and cellular processes that JAK/STAT signaling is involved in that are connected to the beginning and development of disease (<xref ref-type="bibr" rid="B1">Aaronson and Horvath, 2002</xref>; <xref ref-type="bibr" rid="B83">Rawlings et al., 2004</xref>).</p>
<p>Human inter-trypsin inhibitor heavy chain 4 (ITIH4) is an acute phase response protein that is positively regulated by interleukin-6 (IL-6) (<xref ref-type="bibr" rid="B74">Pi&#xf1;eiro et al., 1999</xref>; <xref ref-type="bibr" rid="B48">Liu et al., 2016</xref>), and TIP-&#x3b1; (tumor necrosis factor-&#x3b1;-inducible protein), a newly identified membrane protein secreted by <italic>H. pylori</italic>, is a potent inducer of epithelial-mesenchymal transition (EMT). After the <italic>H. pylori</italic> infection, the secretion of ITIH4 and TIP-&#x3b1;may encourage the production of IL-6 in GC cells, IL-6 can then trigger the expression of p-STAT3, which activates the STAT3 signaling pathway. The IL-6/STAT3 pathway may be activated by Tip-&#x3b1; and ITIH4 to speed up GC (<xref ref-type="bibr" rid="B37">Jove, 2000</xref>; <xref ref-type="bibr" rid="B48">Liu et al., 2016</xref>; <xref ref-type="bibr" rid="B13">Chen et al., 2017</xref>; <xref ref-type="bibr" rid="B93">Suganuma et al., 2021</xref>). TMEFF2 is a signaling transmembrane protein that interacts with two folliclestatin proteins and epidermal growth factor (<xref ref-type="bibr" rid="B17">Costa et al., 2010</xref>; <xref ref-type="bibr" rid="B46">Lin et al., 2011</xref>). TMEFF2 in the GC may not be regulated normally as a result of the <italic>H. pylori</italic> infection. The primary mechanism is that, in the early stages of the <italic>H. pylori</italic> infection, the overexpression of TMEFF2 in healthy gastric mucosa causes the production of SHP-1, a protein tyrosine phosphatase, which inhibits STAT3 activation. A long-lasting the <italic>H. pylori</italic> infection can activate the STAT3 signaling pathway, control STAT3 phosphorylation, and bind directly to the TMEFF2 promoter to suppress TMEFF2 production in the opposite direction (<xref ref-type="bibr" rid="B95">Sun et al., 2015</xref>).</p>
<p>High FGFR4 expression and STAT3 activation levels can result from the <italic>H. pylori</italic> infection. SRC serves as a bridge between STAT3 and FGFR4, indicating that STAT3 is involved in the stimulation of FGFR4 signaling and demonstrating a positive feedback loop between STAT3 and FGFR4 (<xref ref-type="bibr" rid="B115">Zhang et al., 2022b</xref>). Heat shock factor 1 (HSF-1) and phosphorylated STAT-3 interact at the protein level after the <italic>H. pylori</italic> infection of GC cells to produce transcriptionally inactivated HSF-1/STATs complex, which inhibits HSP70 expression, loses its cytoprotective function, and becomes less vulnerable to apoptosis induction (<xref ref-type="bibr" rid="B73">Pierzchalski et al., 2006</xref>). A significant stromal component of many types of malignancies are cancer-associated fibroblasts (CAFs) (<xref ref-type="bibr" rid="B92">Su et al., 2018</xref>), which express smooth muscle actin (&#x3b1;-SMA), fibroblast activating protein, and fibroblast specific protein 1 (FSP-1) (<xref ref-type="bibr" rid="B38">Kalluri, 2016</xref>). By triggering the JAK/STAT1 signaling system, a gastric the <italic>H. pylori</italic> infection can increase the expression of vascular adhesion molecule 1 (VCAM1) in fibroblasts. By connecting with integrin &#x3b1;V&#x3b2;1/5, VCAM1 can facilitate GC cells&#x2019; infiltration into tumors (<xref ref-type="bibr" rid="B88">Shen et al., 2020</xref>) (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>After the <italic>H. pylori</italic> infection, virulence factors can be secreted into cells through the CagA-T4SS secretion system, upregulated ITIH4 and TiP-&#x3b1;, and induced the high expression of IL-6, thus activating the expression of p-STAT3, that is, the STAT3 signaling pathway is activated. After the <italic>H. pylori</italic> infection, TMEFF2 induced upregulation of SHP-1 and inhibited STAT3 phosphorylation. After the <italic>H. pylori</italic> infection, FGFR4 was highly expressed, which upregulated SRC and activated STAT signaling pathway. After the <italic>H. pylori</italic> infection, HF-1 interacts with phosphorylated STAT-3, resulting in the suspension of HSP70 expression. After the <italic>H. pylori</italic> infection, VCAM1 can be upregulated by activating the JAK/STAT1 signaling pathway, and then interact with integrin &#x3b1;v&#x3b2;1/5 to promote tumor invasion. After the activation of STAT signaling pathway, IRF9 can interact with homologous dimers formed by STAT1 and STAT2 on functional IFN stimulatory regulatory elements (ISRE) in the nucleus to regulate the transcription and expression of ISGs.</p>
</caption>
<graphic xlink:href="fcell-11-1187638-g003.tif"/>
</fig>
</sec>
<sec id="s5">
<title>
<italic>Helicobacter pylori</italic> infection induces host cell apoptosis</title>
<p>An active physiological process of cell death is known as apoptosis. By releasing virulence factors, the <italic>H. pylori</italic> infection can activate and regulate the associated proteins, leading to the death of gastric epithelial cells (<xref ref-type="bibr" rid="B91">Steller, 1995</xref>; <xref ref-type="bibr" rid="B3">Ashktorab et al., 2008</xref>). Caspases are the aspartate cysteine protease family&#x2019;s proteasomes, and their activation is typically required for apoptosis to occur (<xref ref-type="bibr" rid="B16">Cohen, 1997</xref>), caspases -3, -6, -8, -9, and -10, for example, like caspase-3 or caspase-6, caspase-8 is a promoter protease (<xref ref-type="bibr" rid="B94">Sun et al., 2006</xref>). The Bcl-2 family is also a sizable collection of proteins linked to apoptosis. In response to varied stimuli, the balance of pro- and anti-apoptotic molecules determines whether the cells survive or perish. Among them, Bcl-2, Bax, and Bcl-XL control the essential proteins of cell death, mostly through influencing mitochondrial function and encouraging the release of cytochrome C (<xref ref-type="bibr" rid="B29">Guo et al., 2019</xref>; <xref ref-type="bibr" rid="B45">Li et al., 2020</xref>; <xref ref-type="bibr" rid="B105">Wu et al., 2020</xref>; <xref ref-type="bibr" rid="B109">Yi et al., 2020</xref>; <xref ref-type="bibr" rid="B50">Liu et al., 2021</xref>). <italic>H. pylori</italic> can regulate the downstream apoptotic factor caspase and the expression of related proteins of apoptosis-related genes p53, Bax, and Fas pathways by activating mitochondria to release cytochrome, triggering the expression of various cell substrates and leading to cell apoptosis by interacting with death receptors in the serous membrane.</p>
<p>Reactive oxygen species (ROS) can cause Ape-1, a multifunctional protein that regulates apoptosis, to be produced (<xref ref-type="bibr" rid="B81">Ramana et al., 1998</xref>). In the exogenous pathway leading to the gastric epithelial cells&#x2019; programmed death after the <italic>H. pylori</italic> infection, APE-1 acetylation is a critical component. Acetylation mutants overexpressing APE-1 prevented caspase-9 activation after the <italic>H. pylori</italic> infection, resulting in decreased expression. The ability of the caspase-8-mediated apoptotic pathway was diminished concurrently (<xref ref-type="bibr" rid="B11">Chattopadhyay et al., 2010</xref>). The src-and C-Abl (non-receptor tyrosine kinases)-mediated phosphorylation of CagA is necessary for an <italic>H. pylori</italic>-mediated cell infection (<xref ref-type="bibr" rid="B76">Poppe et al., 2007</xref>; <xref ref-type="bibr" rid="B59">Mueller et al., 2012</xref>), patients with <italic>H. pylori</italic>-associated gastritis had significantly higher levels of C-Abl in the gastric epithelium and gland. PKC has the ability to directly phosphorylate pAblT735 in gastric epithelial cells. The 14-3-3 protein binds to C-Abl, pushing it to localize in the cytoplasm and inhibiting lowering the production of caspase-8 and caspase-9, blocking the intrinsic apoptotic pathway, and the caspase promoter (<xref ref-type="bibr" rid="B79">Raina et al., 2005</xref>; <xref ref-type="bibr" rid="B53">Maiani et al., 2011</xref>; <xref ref-type="bibr" rid="B77">Posselt et al., 2019</xref>). Patients who have been diagnosed with <italic>H. pylori</italic> have higher levels of IL-18 and IFN-&#x3b3;, IFN-&#x3b3; promotes the cellular synthesis of IL-18, by boosting the production of caspase-3, the intracellular cysteine protease ICE (caspase-1) contributes to the processing of IL-18&#x2019;s active form and to the induction of apoptosis in gastric epithelial cells (<xref ref-type="bibr" rid="B89">Shimada et al., 2008</xref>; <xref ref-type="bibr" rid="B42">Koch and Muller, 2015</xref>). TRAF1, a member of the TRAF family, interacts with various tumor necrosis factor receptors (TNFR) directly or indirectly and inhibits apoptosis in cells by triggering inflammatory pathways. TRAF1 upregulation can be brought on in gastric epithelial cells by <italic>H. pylori</italic>. The virulence factor CagA can prevent the lysis of TRAF1 and the activation of caspase-8 to TRAF1 following the <italic>H. pylori</italic> infection. Consequently, <italic>H. pylori</italic> can persist in the <italic>H. pylori</italic> can therefore persist in the stomach mucosa for a long time without leading to apoptosis (<xref ref-type="bibr" rid="B101">Wan et al., 2016</xref>). By inhibiting FLIP, promoting DISC (death signal inducing complex) assembly by FLIP, activating caspase-8, transmitting the apoptotic signal to the mitochondria, and inducing the release of cytochrome C from the mitochondria into the cytoplasm, <italic>H. pylori</italic> induced TRAIL (tumor necrosis factor-associated apoptosis-inducing ligand) apoptosis signal. Apoptosis resistance can break down when the mitochondrial downstream caspase cascade caspase-9 is triggered (<xref ref-type="bibr" rid="B47">Lin et al., 2014</xref>).</p>
<p>After the <italic>H. pylori</italic> infection, corticosteroids, which activate the actin-related protein complex ARP2/3, can help the acid activate the apoptotic function in gastric epithelial cells (VacA), which in turn causes the pro-apoptotic protein Bax to be induced and the anti-apoptotic protein Bcl-2 to be inhibited. This finally causes target cells to undergo apoptosis (<xref ref-type="bibr" rid="B10">Chang et al., 2016</xref>). Heat shock proteins (HSPs) serve as molecular chaperones that help damaged proteins refold and fold freshly generated cellular proteins. The GC epithelial cells of <italic>H. pylori</italic> are directly affected by the production of CagA and vacA, increasing their fragility and suppressing the expression of HSP70. On the other hand, the balance between Bax and Bcl-2 expression was altered by the downregulation of HSP70 and the absence of its protective effect on the cell defense system.</p>
<p>Additionally, at the same time, Bcl-2, an anti-apoptotic protein, showed decreased expression (<xref ref-type="bibr" rid="B73">Pierzchalski et al., 2006</xref>; <xref ref-type="bibr" rid="B96">Targosz et al., 2012</xref>). Through pathways that depend on VDAC and the Bcl-2 family and cytochrome C, the <italic>H. pylori</italic> virulence factor VacA induces caspase-3, causing the activation of caspase-3 and the execution of apoptosis (<xref ref-type="bibr" rid="B44">Lan et al., 2010</xref>).</p>
</sec>
<sec id="s6">
<title>
<italic>Helicobacter pylori</italic> infection induces DNA methylation in host cells</title>
<p>The most extensively researched epigenetic alteration, DNA methylation, has two primary modification mechanisms. The first step is to modify the cytosine residue of the CpG dinucleotide by adding a methyl group to its fifth carbon (<xref ref-type="bibr" rid="B24">Feinberg and Tycko, 2004</xref>). The second is the gc-rich region of the genome&#x2019;s CpG dinucleotide cluster CpG island (CGI), where abnormal methylation results in transcriptional silence and alters the expression of downstream genes (<xref ref-type="bibr" rid="B78">Qu et al., 2013</xref>; <xref ref-type="bibr" rid="B98">Usui et al., 2021</xref>). Two DNA methylation transferases (DNMTs) catalyze cytosine methylation (<xref ref-type="bibr" rid="B36">Jones and Baylin, 2002</xref>), including DNMT3 family methylases, which participate in <italic>de novo</italic> methylation, and DNMT1, which maintains methylation by methylating newly synthesized DNA strands (<xref ref-type="bibr" rid="B19">Costello and Plass, 2001</xref>; <xref ref-type="bibr" rid="B32">Hashimoto et al., 2010</xref>). One of the primary causes of carcinogenesis is the methylation-induced silence of tumor suppressor genes (<xref ref-type="bibr" rid="B100">Vogelstein et al., 2013</xref>).</p>
<p>Connexins Cx32 and Cx43 connect the space between gastric epithelial cells, and the <italic>H. pylori</italic> infection may result in high levels of methylation of their promoters, which lowers their expression. This inhibits the intercellular communication (GJIC) function of the gastric space junction, which causes GC. The expression of Cx32 and Cx43 decreased during the <italic>H. pylori</italic> infection&#x2019;s chronic atrophic gastritis stage (<xref ref-type="bibr" rid="B103">Wang Y et al., 2014</xref>). In GC, FOXD3 is a tumor suppressor that has been epigenetically silenced. Once a FOXD3 promoter methylation is induced at the transcription start point following the <italic>H. pylori</italic> infection. The tumor suppressor role of FOXD3 in GC was later identified, and its direct transcriptional targets CYFIP2 and RARB may act as a conduit for this role. In human GC, FOXD3 prevents the tumor cascade from being downregulated (<xref ref-type="bibr" rid="B15">Cheng et al., 2013</xref>). Mucous metaplasia, or TFF2, primarily arises from the stomach&#x2019;s bottom. The peptide for muscle crack is known as express solution IM (<xref ref-type="bibr" rid="B90">Soutto et al., 2015</xref>). The main mechanism of the <italic>H. pylori</italic> infection in chronic TFF2 promoter methylation-induced GC cells directly, primarily in the transcription start site of overlapping CpG dinucleotide, is infected cells after startup TFF2 methylation. Consequently, TFF2 expression declines over time (<xref ref-type="bibr" rid="B71">Peterson et al., 2010</xref>). A key regulator of the production of autophagosomes is the microtubule-associated protein 1 light chain 3 (MAP1LC3/LC3) (<xref ref-type="bibr" rid="B82">Ravikumar et al., 2010</xref>). MAP1LC3Av1 methylation silencing, which is mostly controlled by DNA methylation in its promoter region, can result from a long-term infection of gastric epithelial cells with <italic>H. pylori</italic>. This can result in an autophagy pathway of cell carcinogenesis. These findings imply that preventing GC brought on by <italic>H. pylori</italic>-associated epigenetic autophagy damage can be accomplished by utilizing demethylating drugs (<xref ref-type="bibr" rid="B60">Muhammad et al., 2017</xref>).</p>
</sec>
<sec sec-type="discussion" id="s7">
<title>Discussion</title>
<p>The modulation of host proteins in gastric epithelial cells infected with <italic>H. pylori</italic> has been the subject of several investigations. The primary processes of signaling pathways are reviewed in this article, as well as how signaling pathways control the expression of host proteins in GC. For instance, secreted virulence factors regulate the expression of downstream target proteins, activate NF-&#x3ba;B, ERK/MAPK, JAK/STAT, and other signaling pathways or cytokine receptors, enhance or inhibit the inflammatory response after infection, and promote the proliferation and metastasis of GC. Following the <italic>H. pylori</italic> infection, the expression of associated proteins and inflammatory factors is either up- or downregulated, activating the intracellular apoptosis program, starting or stopping the expression of apoptotic proteins, and controlling the associated GC process. Additionally, the <italic>H. pylori</italic> infection can result in DNA methylation, which silences the associated tumor suppressor genes and promotes the growth and spread of cancer.</p>
<p>Despite a thorough examination of the literature, the relevant signaling pathways&#x2014;such as the PI3K-AKT pathway, Wnt/&#x3b2;-Catenin signaling network, and TGF-&#x3b2; signaling pathway&#x2014;presented are not all-inclusive. It is vital to pay attention to the linked host proteins because they influence the onset and prognosis of gastric illnesses brought on by the <italic>H. pylori</italic> infections.</p>
</sec>
</body>
<back>
<sec id="s8">
<title>Author contributions</title>
<p>YX and X-LZ conceived the article and completed the first draft. Q-XL, H-NG, and Y-SL revised and polished the article. S-HS and X-HM directed the structure and content of the thesis and provided funding. All authors read and approved the manuscript.</p>
</sec>
<sec id="s9">
<title>Funding</title>
<p>This study was funded by the National Natural Science Foundation of China (Grant No. 81772157).</p>
</sec>
<ack>
<p>The figures in the manuscript were created with <ext-link ext-link-type="uri" xlink:href="http://BioRender.com">BioRender.com</ext-link>.</p>
</ack>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aaronson</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>C. M.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>A road map for those who don&#x27;t know JAK-STAT</article-title>. <source>Science</source> <volume>296</volume> (<issue>5573</issue>), <fpage>1653</fpage>&#x2013;<lpage>1655</lpage>. <pub-id pub-id-type="doi">10.1126/science.1071545</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aihara</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tsuchimoto</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Takizawa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Azuma</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wakebe</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ohmoto</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>1997</year>). <article-title>Mechanisms involved in Helicobacter pylori-induced interleukin-8 production by a gastric cancer cell line, MKN45</article-title>. <source>Infect. Immun.</source> <volume>65</volume> (<issue>8</issue>), <fpage>3218</fpage>&#x2013;<lpage>3224</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.65.8.3218-3224.1997</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashktorab</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Dashwood</surname>
<given-names>R. H.</given-names>
</name>
<name>
<surname>Dashwood</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Zaidi</surname>
<given-names>S. I.</given-names>
</name>
<name>
<surname>Hewitt</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>W. R.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>
<italic>H. pylori</italic>-induced apoptosis in human gastric cancer cells mediated via the release of apoptosis-inducing factor from mitochondria</article-title>. <source>Helicobacter</source> <volume>13</volume> (<issue>6</issue>), <fpage>506</fpage>&#x2013;<lpage>517</lpage>. <pub-id pub-id-type="doi">10.1111/j.1523-5378.2008.00646.x</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Backert</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tegtmeyer</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Composition, structure and function of the <italic>Helicobacter pylori</italic> cag pathogenicity island encoded type IV secretion system</article-title>. <source>Future Microbiol.</source> <volume>10</volume> (<issue>6</issue>), <fpage>955</fpage>&#x2013;<lpage>965</lpage>. <pub-id pub-id-type="doi">10.2217/fmb.15.32</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bae</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>&#x3b2;-Carotene inhibits expression of matrix metalloproteinase-10 and invasion in <italic>Helicobacter pylori</italic>-infected gastric epithelial cells</article-title>. <source>Molecules</source> <volume>26</volume> (<issue>6</issue>), <fpage>1567</fpage>. <pub-id pub-id-type="doi">10.3390/molecules26061567</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bebb</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Letley</surname>
<given-names>D. P.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Aviles</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>S. A.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>
<italic>Helicobacter pylori</italic> upregulates matrilysin (MMP-7) in epithelial cells <italic>in vivo</italic> and <italic>in vitro</italic> in a Cag dependent manner</article-title>. <source>Gut</source> <volume>52</volume> (<issue>10</issue>), <fpage>1408</fpage>&#x2013;<lpage>1413</lpage>. <pub-id pub-id-type="doi">10.1136/gut.52.10.1408</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boengler</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hilfiker-Kleiner</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Drexler</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Heusch</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Schulz</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>The myocardial JAK/STAT pathway: From protection to failure</article-title>. <source>Pharmacol. Ther.</source> <volume>120</volume> (<issue>2</issue>), <fpage>172</fpage>&#x2013;<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2008.08.002</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brandt</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kwok</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hartig</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>K&#xf6;nig</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Backert</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>NF-kappaB activation and potentiation of proinflammatory responses by the <italic>Helicobacter pylori</italic> CagA protein</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>102</volume> (<issue>26</issue>), <fpage>9300</fpage>&#x2013;<lpage>9305</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0409873102</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Y. L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>The specific roles of JAK/STAT signaling pathway in sepsis</article-title>. <source>Inflammation</source> <volume>38</volume> (<issue>4</issue>), <fpage>1599</fpage>&#x2013;<lpage>1608</lpage>. <pub-id pub-id-type="doi">10.1007/s10753-015-0135-z</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ni</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zuo</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Cortactin mediates apoptosis of gastric epithelial cells induced by VacA protein of <italic>Helicobacter pylori</italic>
</article-title>. <source>Dig. Dis. Sci.</source> <volume>61</volume> (<issue>1</issue>), <fpage>80</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1007/s10620-015-3836-0</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chattopadhyay</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bhattacharyya</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Crowe</surname>
<given-names>S. E.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Dual regulation by apurinic/apyrimidinic endonuclease-1 inhibits gastric epithelial cell apoptosis during <italic>Helicobacter pylori</italic> infection</article-title>. <source>Cancer Res.</source> <volume>70</volume> (<issue>7</issue>), <fpage>2799</fpage>&#x2013;<lpage>2808</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-09-4136</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>G. Y.</given-names>
</name>
<name>
<surname>Shu</surname>
<given-names>Y. C.</given-names>
</name>
<name>
<surname>Chuang</surname>
<given-names>D. Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y. C.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Inflammatory and apoptotic regulatory activity of Tanshinone IIA in Helicobacter pylori-infected cells</article-title>. <source>Am. J. Chin. Med.</source> <volume>44</volume> (<issue>6</issue>), <fpage>1187</fpage>&#x2013;<lpage>1206</lpage>. <pub-id pub-id-type="doi">10.1142/S0192415X1650066X</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>TNF-alpha-inducing protein of <italic>Helicobacter pylori</italic> induces epithelial-mesenchymal transition (EMT) in gastric cancer cells through activation of IL-6/STAT3 signaling pathway</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>484</volume> (<issue>2</issue>), <fpage>311</fpage>&#x2013;<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2017.01.110</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sheppard</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>
<italic>H. pylori</italic> infection confers resistance to apoptosis via Brd4-dependent BIRC3 eRNA synthesis</article-title>. <source>Cell. Death Dis.</source> <volume>11</volume> (<issue>8</issue>), <fpage>667</fpage>. <pub-id pub-id-type="doi">10.1038/s41419-020-02894-z</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>V. Y.</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Lau</surname>
<given-names>S. S.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>
<italic>Helicobacter pylori</italic> causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis</article-title>. <source>Gastroenterology</source> <volume>144</volume> (<issue>1</issue>), <fpage>122</fpage>&#x2013;<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2012.10.002</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname>
<given-names>G. M.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Caspases: The executioners of apoptosis</article-title>. <source>Biochem. J.</source> <volume>326</volume>, <fpage>1</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1042/bj3260001</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costa</surname>
<given-names>V. L.</given-names>
</name>
<name>
<surname>Henrique</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Danielsen</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Duarte-Pereira</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Eknaes</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Skotheim</surname>
<given-names>R. I.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samples</article-title>. <source>Clin. Cancer Res.</source> <volume>16</volume> (<issue>23</issue>), <fpage>5842</fpage>&#x2013;<lpage>5851</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-10-1312</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costa</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Pinto-Ribeiro</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Sougleri</surname>
<given-names>I. S.</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Carreto</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>
<italic>Helicobacter pylori</italic> activates matrix metalloproteinase 10 in gastric epithelial cells via EGFR and ERK-mediated pathways</article-title>. <source>J. Infect. Dis.</source> <volume>213</volume> (<issue>11</issue>), <fpage>1767</fpage>&#x2013;<lpage>1776</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jiw031</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costello</surname>
<given-names>J. F.</given-names>
</name>
<name>
<surname>Plass</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Methylation matters</article-title>. <source>J. Med. Genet.</source> <volume>38</volume> (<issue>5</issue>), <fpage>285</fpage>&#x2013;<lpage>303</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.38.5.285</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cover</surname>
<given-names>T. L.</given-names>
</name>
<name>
<surname>Blanke</surname>
<given-names>S. R.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>
<italic>Helicobacter pylori</italic> VacA, a paradigm for toxin multifunctionality</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>3</volume> (<issue>4</issue>), <fpage>320</fpage>&#x2013;<lpage>332</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro1095</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crowe</surname>
<given-names>S. E.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>
<italic>Helicobacter pylori</italic> infection</article-title>. <source>N. Engl. J. Med.</source> <volume>380</volume> (<issue>12</issue>), <fpage>1158</fpage>&#x2013;<lpage>1165</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMcp1710945</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dickson</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Grabowska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>El-Zaatari</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Atherton</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>S. A.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>
<italic>Helicobacter pylori</italic> can induce heparin-binding epidermal growth factor expression via gastrin and its receptor</article-title>. <source>Cancer Res.</source> <volume>66</volume> (<issue>15</issue>), <fpage>7524</fpage>&#x2013;<lpage>7531</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-3246</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname>
<given-names>S. Z.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>M. F.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Goldberg</surname>
<given-names>J. B.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>
<italic>Helicobacter pylori</italic> and mitogen-activated protein kinases regulate the cell cycle, proliferation and apoptosis in gastric epithelial cells</article-title>. <source>J. Gastroenterol. Hepatol.</source> <volume>23</volume>, <fpage>e67</fpage>&#x2013;<lpage>e78</lpage>. <pub-id pub-id-type="doi">10.1111/j.1440-1746.2007.04912.x</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feinberg</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Tycko</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>The history of cancer epigenetics</article-title>. <source>Nat. Rev. Cancer</source> <volume>4</volume> (<issue>2</issue>), <fpage>143</fpage>&#x2013;<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1038/nrc1279</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fischer</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>P&#xfc;ls</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Buhrdorf</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gebert</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Odenbreit</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Haas</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Systematic mutagenesis of the <italic>Helicobacter pylori</italic> cag pathogenicity island: Essential genes for CagA translocation in host cells and induction of interleukin-8</article-title>. <source>Mol. Microbiol.</source> <volume>42</volume> (<issue>5</issue>), <fpage>1337</fpage>&#x2013;<lpage>1348</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2958.2001.02714.x</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W. T.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Z. G.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell</article-title>. <source>World J. Gastroenterol.</source> <volume>24</volume> (<issue>24</issue>), <fpage>2567</fpage>&#x2013;<lpage>2581</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v24.i24.2567</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gemel</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Matiukas</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Veenstra</surname>
<given-names>R. D.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Degradation of a connexin40 mutant linked to atrial fibrillation is accelerated</article-title>. <source>J. Mol. Cell. Cardiol.</source> <volume>74</volume>, <fpage>330</fpage>&#x2013;<lpage>339</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2014.06.010</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>G&#xf6;&#xf5;z</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>G&#xf6;&#xf5;z</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Smolka</surname>
<given-names>A. J.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Epithelial and bacterial metalloproteinases and their inhibitors in <italic>H. pylori</italic> infection of human gastric cells</article-title>. <source>Am. J. Physiol. Gastrointest. Liver Physiol.</source> <volume>281</volume> (<issue>3</issue>), <fpage>G823</fpage>&#x2013;<lpage>G832</lpage>. <pub-id pub-id-type="doi">10.1152/ajpgi.2001.281.3.G823</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Jing</surname>
<given-names>F. J.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>X. M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Ubenimex reverses MDR in gastric cancer cells by activating caspase-3-mediated apoptosis and suppressing the expression of membrane transport proteins</article-title>. <source>Biomed. Res. Int.</source> <volume>2019</volume>, <fpage>4390839</fpage>. <pub-id pub-id-type="doi">10.1155/2019/4390839</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2020a</year>). <article-title>
<italic>Helicobacter pylori</italic> inhibits GKN1 expression via the CagA/p-ERK/AUF1 pathway</article-title>. <source>Helicobacter</source> <volume>25</volume> (<issue>1</issue>), <fpage>e12665</fpage>. <pub-id pub-id-type="doi">10.1111/hel.12665</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>W. W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Z. F.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>L. L.</given-names>
</name>
</person-group> (<year>2020b</year>). <article-title>ERK/MAPK signalling pathway and tumorigenesis</article-title>. <source>Exp. Ther. Med.</source> <volume>19</volume> (<issue>3</issue>), <fpage>1997</fpage>&#x2013;<lpage>2007</lpage>. <pub-id pub-id-type="doi">10.3892/etm.2020.8454</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hashimoto</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Vertino</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Molecular coupling of DNA methylation and histone methylation</article-title>. <source>Epigenomics</source> <volume>2</volume> (<issue>5</issue>), <fpage>657</fpage>&#x2013;<lpage>669</lpage>. <pub-id pub-id-type="doi">10.2217/epi.10.44</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hayden</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>NF-&#x3ba;B in immunobiology</article-title>. <source>Cell. Res.</source> <volume>21</volume> (<issue>2</issue>), <fpage>223</fpage>&#x2013;<lpage>244</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2011.13</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hojo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Miwa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kikuchi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Do mucosal defensive agents improve the cure rate when used with dual or triple therapy regimens for eradicating <italic>Helicobacter pylori</italic> infection?</article-title> <source>Aliment. Pharmacol. Ther.</source> <volume>14</volume> (<issue>2</issue>), <fpage>193</fpage>&#x2013;<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2036.2000.00692.x</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Ouyang</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>
<italic>Helicobacter pylori</italic> infection promotes the invasion and metastasis of gastric cancer through increasing the expression of matrix metalloproteinase-1 and matrix metalloproteinase-10</article-title>. <source>Exp. Ther. Med.</source> <volume>8</volume> (<issue>3</issue>), <fpage>769</fpage>&#x2013;<lpage>774</lpage>. <pub-id pub-id-type="doi">10.3892/etm.2014.1822</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Baylin</surname>
<given-names>S. B.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>The fundamental role of epigenetic events in cancer</article-title>. <source>Nat. Rev. Genet.</source> <volume>3</volume> (<issue>6</issue>), <fpage>415</fpage>&#x2013;<lpage>428</lpage>. <pub-id pub-id-type="doi">10.1038/nrg816</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jove</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Preface: STAT signaling</article-title>. <source>Oncogene</source> <volume>19</volume> (<issue>21</issue>), <fpage>2466</fpage>&#x2013;<lpage>2467</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1203549</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalluri</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>The biology and function of fibroblasts in cancer</article-title>. <source>Nat. Rev. Cancer</source> <volume>16</volume> (<issue>9</issue>), <fpage>582</fpage>&#x2013;<lpage>598</lpage>. <pub-id pub-id-type="doi">10.1038/nrc.2016.73</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Amit</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Yarden</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Regulation of MAPKs by growth factors and receptor tyrosine kinases</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1773</volume> (<issue>8</issue>), <fpage>1161</fpage>&#x2013;<lpage>1176</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2007.01.002</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khanna</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chua</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Bay</surname>
<given-names>B. H.</given-names>
</name>
<name>
<surname>Baeg</surname>
<given-names>G. H.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>The JAK/STAT signaling cascade in gastric carcinoma (Review)</article-title>. <source>Int. J. Oncol.</source> <volume>47</volume> (<issue>5</issue>), <fpage>1617</fpage>&#x2013;<lpage>1626</lpage>. <pub-id pub-id-type="doi">10.3892/ijo.2015.3160</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kimura</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Goto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ihara</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wada</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yahiro</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Niidome</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2001</year>). <article-title>Impairment of glutathione metabolism in human gastric epithelial cells treated with vacuolating cytotoxin from <italic>Helicobacter pylori</italic>
</article-title>. <source>Microb. Pathog.</source> <volume>31</volume> (<issue>1</issue>), <fpage>29</fpage>&#x2013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1006/mpat.2001.0446</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koch</surname>
<given-names>K. N.</given-names>
</name>
<name>
<surname>Muller</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>
<italic>Helicobacter pylori</italic> activates the TLR2/NLRP3/caspase-1/IL-18 axis to induce regulatory T-cells, establish persistent infection and promote tolerance to allergens</article-title>. <source>Gut Microbes</source> <volume>6</volume> (<issue>6</issue>), <fpage>382</fpage>&#x2013;<lpage>387</lpage>. <pub-id pub-id-type="doi">10.1080/19490976.2015.1105427</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krueger</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hundertmark</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kalinski</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Peitz</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Wex</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Malfertheiner</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>
<italic>Helicobacter pylori</italic> encoding the pathogenicity island activates matrix metalloproteinase 1 in gastric epithelial cells via JNK and ERK</article-title>. <source>J. Biol. Chem.</source> <volume>281</volume> (<issue>5</issue>), <fpage>2868</fpage>&#x2013;<lpage>2875</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M511053200</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lan</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>J. Q.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>Q. Z.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>L. L.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Z. R.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Involvement of VDAC1 and Bcl-2 family of proteins in VacA-induced cytochrome c release and apoptosis of gastric epithelial carcinoma cells</article-title>. <source>J. Dig. Dis.</source> <volume>11</volume> (<issue>1</issue>), <fpage>43</fpage>&#x2013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1111/j.1751-2980.2009.00412.x</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Destruction of neutrophil extracellular traps promotes the apoptosis and inhibits the invasion of gastric cancer cells by regulating the expression of bcl-2, Bax and NF-&#x3ba;B</article-title>. <source>OncoTargets Ther.</source> <volume>Vol. 13</volume>, <fpage>5271</fpage>&#x2013;<lpage>5281</lpage>. <pub-id pub-id-type="doi">10.2147/OTT.S227331</pub-id>&#x3c;</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>J. R.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Wu</surname>
<given-names>T. D.</given-names>
</name>
<name>
<surname>Gutierrez</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Elliott</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Vernes</surname>
<given-names>J. M.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>TMEFF2 is a PDGF-AA binding protein with methylation-associated gene silencing in multiple cancer types including glioma</article-title>. <source>PLoS One</source> <volume>6</volume> (<issue>4</issue>), <fpage>e18608</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0018608</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>W. C.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>H. F.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y. Y.</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>P. I.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>
<italic>Helicobacter pylori</italic> sensitizes TNF-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human gastric epithelial cells through regulation of FLIP</article-title>. <source>Cell. Death Dis.</source> <volume>5</volume>, <fpage>e1109</fpage>. <pub-id pub-id-type="doi">10.1038/cddis.2014.81</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Interleukin-6-stimulated progranulin expression contributes to the malignancy of hepatocellular carcinoma cells by activating mTOR signaling</article-title>. <source>Sci. Rep.</source> <volume>6</volume>, <fpage>21260</fpage>. <pub-id pub-id-type="doi">10.1038/srep21260</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Joo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>S. C.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>NF-kappaB signaling in inflammation</article-title>. <source>Signal Transduct. Target Ther.</source> <volume>2</volume>, <fpage>17023</fpage>. <pub-id pub-id-type="doi">10.1038/sigtrans.2017.23</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J. F.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>X. Z.</given-names>
</name>
<name>
<surname>Cong</surname>
<given-names>H. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Acute and chronic infection of <italic>H. pylori</italic> caused the difference in apoptosis of gastric epithelial cells</article-title>. <source>Microb. Pathog.</source> <volume>150</volume>, <fpage>104717</fpage>. <pub-id pub-id-type="doi">10.1016/j.micpath.2020.104717</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Machlowska</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Baj</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sitarz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Maciejewski</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sitarz</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Gastric cancer: Epidemiology, risk factors, classification, genomic characteristics and treatment strategies</article-title>. <source>Int. J. Mol. Sci.</source> <volume>21</volume> (<issue>11</issue>), <fpage>4012</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21114012</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maeda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ogura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mitsuno</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hirata</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yamaji</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2000</year>). <article-title>
<italic>H. pylori</italic> activates NF-kappaB through a signaling pathway involving IkappaB kinases, NF-kappaB-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells</article-title>. <source>Gastroenterology</source> <volume>119</volume> (<issue>1</issue>), <fpage>97</fpage>&#x2013;<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1053/gast.2000.8540</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maiani</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Diederich</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gonfloni</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>DNA damage response: The emerging role of c-abl as a regulatory switch?</article-title> <source>Biochem. Pharmacol.</source> <volume>82</volume> (<issue>10</issue>), <fpage>1269</fpage>&#x2013;<lpage>1276</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2011.07.001</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maubach</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sokolova</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Wolfien</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rothkotter</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Naumann</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Ca2&#x2b;/calmodulin-dependent kinase II contributes to inhibitor of nuclear factor-kappa B kinase complex activation in <italic>Helicobacter pylori</italic> infection</article-title>. <source>Int. J. Cancer</source> <volume>133</volume> (<issue>6</issue>), <fpage>1507</fpage>&#x2013;<lpage>1512</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.28148</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maubach</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>M. C. C.</given-names>
</name>
<name>
<surname>Sokolova</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Backert</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>T. F.</given-names>
</name>
<name>
<surname>Naumann</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>TIFA has dual functions in Helicobacter pylori-induced classical and alternative NF-&#x3ba;B pathways</article-title>. <source>EMBO Rep.</source> <volume>22</volume> (<issue>9</issue>), <fpage>e52878</fpage>. <pub-id pub-id-type="doi">10.15252/embr.202152878</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maubach</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Vieth</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Boccellato</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Naumann</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Helicobacter pylori-induced NF-&#x3ba;B: Trailblazer for gastric pathophysiology</article-title>. <source>Trends Mol. Med.</source> <volume>28</volume> (<issue>3</issue>), <fpage>210</fpage>&#x2013;<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmed.2021.12.005</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mejias-Luque</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zoller</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Anderl</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Loew-Gil</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Vieth</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Adler</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Lymphotoxin beta receptor signalling executes Helicobacter pylori-driven gastric inflammation in a T4SS-dependent manner</article-title>. <source>Gut</source> <volume>66</volume> (<issue>8</issue>), <fpage>1369</fpage>&#x2013;<lpage>1381</lpage>. <pub-id pub-id-type="doi">10.1136/gutjnl-2015-310783</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mori</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hayashibara</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Senba</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Geleziunas</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wada</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>
<italic>Helicobacter pylori</italic> induces matrix metalloproteinase-9 through activation of nuclear factor kappaB</article-title>. <source>Gastroenterology</source> <volume>124</volume> (<issue>4</issue>), <fpage>983</fpage>&#x2013;<lpage>992</lpage>. <pub-id pub-id-type="doi">10.1053/gast.2003.50152</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mueller</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tegtmeyer</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Brandt</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yamaoka</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>De Poire</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sgouras</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian <italic>Helicobacter pylori</italic> strains</article-title>. <source>J. Clin. Invest.</source> <volume>122</volume> (<issue>4</issue>), <fpage>1553</fpage>&#x2013;<lpage>1566</lpage>. <pub-id pub-id-type="doi">10.1172/JCI61143</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muhammad</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Nanjo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ando</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yamashita</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Maekita</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ushijima</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Autophagy impairment by Helicobacter pylori-induced methylation silencing of MAP1LC3Av1 promotes gastric carcinogenesis</article-title>. <source>Int. J. Cancer</source> <volume>140</volume> (<issue>10</issue>), <fpage>2272</fpage>&#x2013;<lpage>2283</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.30657</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muller</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Multistep activation of the <italic>Helicobacter pylori</italic> effector CagA</article-title>. <source>J. Clin. Invest.</source> <volume>122</volume> (<issue>4</issue>), <fpage>1192</fpage>&#x2013;<lpage>1195</lpage>. <pub-id pub-id-type="doi">10.1172/JCI61578</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neumann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Naumann</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Beyond IkappaBs: Alternative regulation of NF-kappaB activity</article-title>. <source>FASEB J.</source> <volume>21</volume> (<issue>11</issue>), <fpage>2642</fpage>&#x2013;<lpage>2654</lpage>. <pub-id pub-id-type="doi">10.1096/fj.06-7615rev</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ng</surname>
<given-names>G. Z.</given-names>
</name>
<name>
<surname>Menheniott</surname>
<given-names>T. R.</given-names>
</name>
<name>
<surname>Every</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Stent</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Judd</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Chionh</surname>
<given-names>Y. T.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>The MUC1 mucin protects against <italic>Helicobacter pylori</italic> pathogenesis in mice by regulation of the NLRP3 inflammasome</article-title>. <source>Gut</source> <volume>65</volume> (<issue>7</issue>), <fpage>1087</fpage>&#x2013;<lpage>1099</lpage>. <pub-id pub-id-type="doi">10.1136/gutjnl-2014-307175</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noto</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Peek</surname>
<given-names>R. M.</given-names>
<suffix>Jr</suffix>
</name>
</person-group> (<year>2012</year>). <article-title>
<italic>Helicobacter pylori</italic>: An overview</article-title>. <source>Methods Mol. Biol.</source> <volume>921</volume>, <fpage>7</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-62703-005-2_2</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Odenbreit</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Puls</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sedlmaier</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gerland</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Haas</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Translocation of <italic>Helicobacter pylori</italic> CagA into gastric epithelial cells by type IV secretion</article-title>. <source>Science</source> <volume>287</volume> (<issue>5457</issue>), <fpage>1497</fpage>&#x2013;<lpage>1500</lpage>. <pub-id pub-id-type="doi">10.1126/science.287.5457.1497</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogasa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Miyazaki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hiraoka</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kitamura</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nagasawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kishida</surname>
<given-names>O.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Gastrin activates nuclear factor kappaB (NFkappaB) through a protein kinase C dependent pathway involving NFkappaB inducing kinase, inhibitor kappaB (IkappaB) kinase, and tumour necrosis factor receptor associated factor 6 (TRAF6) in MKN-28 cells transfected with gastrin receptor</article-title>. <source>Gut</source> <volume>52</volume> (<issue>6</issue>), <fpage>813</fpage>&#x2013;<lpage>819</lpage>. <pub-id pub-id-type="doi">10.1136/gut.52.6.813</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palframan</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Kwok</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gabriel</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Vacuolating cytotoxin A (VacA), a key toxin for <italic>Helicobacter pylori</italic> pathogenesis</article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>2</volume>, <fpage>92</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2012.00092</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pathak</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Tavares</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>de Klerk</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Spetz</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Jonsson</surname>
<given-names>A. B.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>
<italic>Helicobacter pylori</italic> protein JHP0290 binds to multiple cell types and induces macrophage apoptosis via tumor necrosis factor (TNF)-dependent and independent pathways</article-title>. <source>PLoS One</source> <volume>8</volume> (<issue>11</issue>), <fpage>e77872</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0077872</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ouyang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The NF-&#x3ba;B signaling pathway, the microbiota, and gastrointestinal tumorigenesis: Recent advances</article-title>. <source>Front. Immunol.</source> <volume>11</volume>, <fpage>1387</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2020.01387</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perrais</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rousseaux</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ducourouble</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Courcol</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Vincent</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Jonckheere</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>
<italic>Helicobacter pylori</italic> urease and flagellin alter mucin gene expression in human gastric cancer cells</article-title>. <source>Gastric Cancer</source> <volume>17</volume> (<issue>2</issue>), <fpage>235</fpage>&#x2013;<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1007/s10120-013-0267-5</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peterson</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Menheniott</surname>
<given-names>T. R.</given-names>
</name>
<name>
<surname>O&#x27;Connor</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Walduck</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>J. G.</given-names>
</name>
<name>
<surname>Kawakami</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>
<italic>Helicobacter pylori</italic> infection promotes methylation and silencing of trefoil factor 2, leading to gastric tumor development in mice and humans</article-title>. <source>Gastroenterology</source> <volume>139</volume> (<issue>6</issue>), <fpage>2005</fpage>&#x2013;<lpage>2017</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2010.08.043</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petryszyn</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chapelle</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Matysiak-Budnik</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Gastric cancer: Where are we heading?</article-title> <source>Dig. Dis.</source> <volume>38</volume> (<issue>4</issue>), <fpage>280</fpage>&#x2013;<lpage>285</lpage>. <pub-id pub-id-type="doi">10.1159/000506509</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pierzchalski</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Krawiec</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ptak-Belowska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bara&#x144;ska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Konturek</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Pawlik</surname>
<given-names>W. W.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>The mechanism of heat-shock protein 70 gene expression abolition in gastric epithelium caused by <italic>Helicobacter pylori</italic> infection</article-title>. <source>Helicobacter</source> <volume>11</volume> (<issue>2</issue>), <fpage>96</fpage>&#x2013;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1111/j.1523-5378.2006.00383.x</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pi&#xf1;eiro</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Alava</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Gonz&#xe1;lez-Ram&#xf3;n</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Osada</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lasierra</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Larrad</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>1999</year>). <article-title>ITIH4 serum concentration increases during acute-phase processes in human patients and is up-regulated by interleukin-6 in hepatocarcinoma HepG2 cells</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>263</volume> (<issue>1</issue>), <fpage>224</fpage>&#x2013;<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1006/bbrc.1999.1349</pub-id>
</citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plotnikov</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zehorai</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Procaccia</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Seger</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>The MAPK cascades: Signaling components, nuclear roles and mechanisms of nuclear translocation</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1813</volume> (<issue>9</issue>), <fpage>1619</fpage>&#x2013;<lpage>1633</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2010.12.012</pub-id>
</citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poppe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Feller</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Romer</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wessler</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Phosphorylation of <italic>Helicobacter pylori</italic> CagA by c-Abl leads to cell motility</article-title>. <source>Oncogene</source> <volume>26</volume> (<issue>24</issue>), <fpage>3462</fpage>&#x2013;<lpage>3472</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1210139</pub-id>
</citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Posselt</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wiesauer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chichirau</surname>
<given-names>B. E.</given-names>
</name>
<name>
<surname>Engler</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Krisch</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Gadermaier</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Helicobacter pylori-controlled c-Abl localization promotes cell migration and limits apoptosis</article-title>. <source>Cell. Commun. Signal</source> <volume>17</volume> (<issue>1</issue>), <fpage>10</fpage>. <pub-id pub-id-type="doi">10.1186/s12964-019-0323-9</pub-id>
</citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Gene methylation in gastric cancer</article-title>. <source>Clin. Chim. Acta</source> <volume>424</volume>, <fpage>53</fpage>&#x2013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.cca.2013.05.002</pub-id>
</citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raina</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pandey</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bharti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kharbanda</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>c-Abl tyrosine kinase regulates caspase-9 autocleavage in the apoptotic response to DNA damage</article-title>. <source>J. Biol. Chem.</source> <volume>280</volume> (<issue>12</issue>), <fpage>11147</fpage>&#x2013;<lpage>11151</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M413787200</pub-id>
</citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raju</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hussey</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Terebiznik</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Sibony</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Galindo-Mata</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote <italic>Helicobacter pylori</italic> infection in humans</article-title>. <source>Gastroenterology</source> <volume>142</volume> (<issue>5</issue>), <fpage>1160</fpage>&#x2013;<lpage>1171</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2012.01.043</pub-id>
</citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramana</surname>
<given-names>C. V.</given-names>
</name>
<name>
<surname>Boldogh</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Izumi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mitra</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>95</volume> (<issue>9</issue>), <fpage>5061</fpage>&#x2013;<lpage>5066</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.9.5061</pub-id>
</citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ravikumar</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sarkar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Futter</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Garcia-Arencibia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Green-Thompson</surname>
<given-names>Z. W.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Regulation of mammalian autophagy in physiology and pathophysiology</article-title>. <source>Physiol. Rev.</source> <volume>90</volume> (<issue>4</issue>), <fpage>1383</fpage>&#x2013;<lpage>1435</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00030.2009</pub-id>
</citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rawlings</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Rosler</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>D. A.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>The JAK/STAT signaling pathway</article-title>. <source>J. Cell. Sci.</source> <volume>117</volume> (<issue>8</issue>), <fpage>1281</fpage>&#x2013;<lpage>1283</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.00963</pub-id>
</citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sabio</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>R. J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>TNF and MAP kinase signalling pathways</article-title>. <source>Seminars Immunol.</source> <volume>26</volume> (<issue>3</issue>), <fpage>237</fpage>&#x2013;<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1016/j.smim.2014.02.009</pub-id>
</citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakitani</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hirata</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hayakawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Serizawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nakata</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Role of interleukin-32 in Helicobacter pylori-induced gastric inflammation</article-title>. <source>Infect. Immun.</source> <volume>80</volume> (<issue>11</issue>), <fpage>3795</fpage>&#x2013;<lpage>3803</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00637-12</pub-id>
</citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sebkova</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pellicano</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Monteleone</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Grazioli</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Guarnieri</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Imeneo</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Extracellular signal-regulated protein kinase mediates interleukin 17 (IL-17)-induced IL-8 secretion in Helicobacter pylori-infected human gastric epithelial cells</article-title>. <source>Infect. Immun.</source> <volume>72</volume> (<issue>9</issue>), <fpage>5019</fpage>&#x2013;<lpage>5026</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.72.9.5019-5026.2004</pub-id>
</citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaffer</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Gaddy</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Loh</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hennig</surname>
<given-names>E. E.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>
<italic>Helicobacter pylori</italic> exploits a unique repertoire of type IV secretion system components for pilus assembly at the bacteria-host cell interface</article-title>. <source>PLoS Pathog.</source> <volume>7</volume> (<issue>9</issue>), <fpage>e1002237</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1002237</pub-id>
</citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>You</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Cancer-associated fibroblasts-derived VCAM1 induced by <italic>H. pylori</italic> infection facilitates tumor invasion in gastric cancer</article-title>. <source>Oncogene</source> <volume>39</volume> (<issue>14</issue>), <fpage>2961</fpage>&#x2013;<lpage>2974</lpage>. <pub-id pub-id-type="doi">10.1038/s41388-020-1197-4</pub-id>
</citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shimada</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ando</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Peek</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Ishiguro</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>O.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>
<italic>Helicobacter pylori</italic> infection upregulates interleukin-18 production from gastric epithelial cells</article-title>. <source>Eur. J. Gastroenterol. Hepatol.</source> <volume>20</volume> (<issue>12</issue>), <fpage>1144</fpage>&#x2013;<lpage>1150</lpage>. <pub-id pub-id-type="doi">10.1097/MEG.0b013e32830edb15</pub-id>
</citation>
</ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soutto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Romero-Gallo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Krishna</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Piazuelo</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Washington</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Belkhiri</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Loss of TFF1 promotes Helicobacter pylori-induced &#x3b2;-catenin activation and gastric tumorigenesis</article-title>. <source>Oncotarget</source> <volume>6</volume> (<issue>20</issue>), <fpage>17911</fpage>&#x2013;<lpage>17922</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.3772</pub-id>
</citation>
</ref>
<ref id="B91">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steller</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Mechanisms and genes of cellular suicide</article-title>. <source>Science</source> <volume>267</volume> (<issue>5203</issue>), <fpage>1445</fpage>&#x2013;<lpage>1449</lpage>. <pub-id pub-id-type="doi">10.1126/science.7878463</pub-id>
</citation>
</ref>
<ref id="B92">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lao</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>CD10(&#x2b;)GPR77(&#x2b;) cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness</article-title>. <source>Cell.</source> <volume>172</volume> (<issue>4</issue>), <fpage>841</fpage>&#x2013;<lpage>856</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.01.009</pub-id>
</citation>
</ref>
<ref id="B93">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suganuma</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sueoka</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>I. K.</given-names>
</name>
<name>
<surname>Fujiki</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Role of TNF-&#x3b1;-inducing protein secreted by <italic>Helicobacter pylori</italic> as a tumor promoter in gastric cancer and emerging preventive strategies</article-title>. <source>Toxins (Basel)</source> <volume>13</volume> (<issue>3</issue>), <fpage>181</fpage>. <pub-id pub-id-type="doi">10.3390/toxins13030181</pub-id>
</citation>
</ref>
<ref id="B94">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X. Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>X. X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X. W.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>Q. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>Differential caspase-3 expression in noncancerous, premalignant and cancer tissues of stomach and its clinical implication</article-title>. <source>Cancer Detect Prev.</source> <volume>30</volume> (<issue>2</issue>), <fpage>168</fpage>&#x2013;<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1016/j.cdp.2006.02.004</pub-id>
</citation>
</ref>
<ref id="B95">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>T. T.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S. L.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Bidirectional regulation between TMEFF2 and STAT3 may contribute to Helicobacter pylori-associated gastric carcinogenesis</article-title>. <source>Int. J. Cancer</source> <volume>136</volume> (<issue>5</issue>), <fpage>1053</fpage>&#x2013;<lpage>1064</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.29061</pub-id>
</citation>
</ref>
<ref id="B96">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Targosz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Brzozowski</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Pierzchalski</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Szczyrk</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Ptak-Belowska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Konturek</surname>
<given-names>S. J.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>
<italic>Helicobacter pylori</italic> promotes apoptosis, activates cyclooxygenase (COX)-2 and inhibits heat shock protein HSP70 in gastric cancer epithelial cells</article-title>. <source>Inflamm. Res.</source> <volume>61</volume> (<issue>9</issue>), <fpage>955</fpage>&#x2013;<lpage>966</lpage>. <pub-id pub-id-type="doi">10.1007/s00011-012-0487-x</pub-id>
</citation>
</ref>
<ref id="B97">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tavares</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pathak</surname>
<given-names>S. K.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>
<italic>Helicobacter pylori</italic> protein JHP0290 exhibits proliferative and anti-apoptotic effects in gastric epithelial cells</article-title>. <source>PLoS One</source> <volume>10</volume> (<issue>4</issue>), <fpage>e0124407</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0124407</pub-id>
</citation>
</ref>
<ref id="B98">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Usui</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Matsusaka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mano</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Urabe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Funata</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fukayama</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>DNA methylation and genetic aberrations in gastric cancer</article-title>. <source>Digestion</source> <volume>102</volume> (<issue>1</issue>), <fpage>25</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1159/000511243</pub-id>
</citation>
</ref>
<ref id="B99">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vinken</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vanhaecke</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Papeleu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Snykers</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Henkens</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Rogiers</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Connexins and their channels in cell growth and cell death</article-title>. <source>Cell. Signal</source> <volume>18</volume> (<issue>5</issue>), <fpage>592</fpage>&#x2013;<lpage>600</lpage>. <pub-id pub-id-type="doi">10.1016/j.cellsig.2005.08.012</pub-id>
</citation>
</ref>
<ref id="B100">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vogelstein</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Papadopoulos</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Velculescu</surname>
<given-names>V. E.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Diaz</surname>
<given-names>L. A.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Kinzler</surname>
<given-names>K. W.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Cancer genome landscapes</article-title>. <source>Science</source> <volume>339</volume> (<issue>6127</issue>), <fpage>1546</fpage>&#x2013;<lpage>1558</lpage>. <pub-id pub-id-type="doi">10.1126/science.1235122</pub-id>
</citation>
</ref>
<ref id="B101">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wan</surname>
<given-names>X. K.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y. C.</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>H. X.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>Z. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>
<italic>Helicobacter pylori</italic> inhibits the cleavage of TRAF1 via a CagA-dependent mechanism</article-title>. <source>World J. Gastroenterol.</source> <volume>22</volume> (<issue>48</issue>), <fpage>10566</fpage>&#x2013;<lpage>10574</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v22.i48.10566</pub-id>
</citation>
</ref>
<ref id="B102">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang F</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Qiao</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Helicobacter pylori-induced gastric inflammation and gastric cancer</article-title>. <source>Cancer Lett.</source> <volume>345</volume> (<issue>2</issue>), <fpage>196</fpage>&#x2013;<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2013.08.016</pub-id>
</citation>
</ref>
<ref id="B103">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang Y</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>L. H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>C. X.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Connexin 32 and 43 promoter methylation in Helicobacter pylori-associated gastric tumorigenesis</article-title>. <source>World J. Gastroenterol.</source> <volume>20</volume> (<issue>33</issue>), <fpage>11770</fpage>&#x2013;<lpage>11779</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v20.i33.11770</pub-id>
</citation>
</ref>
<ref id="B104">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wroblewski</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Peek</surname>
<given-names>R. M.</given-names>
<suffix>Jr</suffix>
</name>
</person-group> (<year>2016</year>). <article-title>
<italic>Helicobacter pylori</italic>, cancer, and the gastric microbiota</article-title>. <source>Adv. Exp. Med. Biol.</source> <volume>908</volume>, <fpage>393</fpage>&#x2013;<lpage>408</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-319-41388-4_19</pub-id>
</citation>
</ref>
<ref id="B105">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>MAC30 knockdown inhibits proliferation and enhance apoptosis of gastric cancer by suppressing wnt/&#x3b2;-cateninsignaling pathway</article-title>. <source>Gastroenterol. Res. Pract.</source> <volume>2020</volume>, <fpage>6358685</fpage>. <pub-id pub-id-type="doi">10.1155/2020/6358685</pub-id>
</citation>
</ref>
<ref id="B106">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>The role of JAK/STAT signaling pathway and its inhibitors in diseases</article-title>. <source>Int. Immunopharmacol.</source> <volume>80</volume>, <fpage>106210</fpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2020.106210</pub-id>
</citation>
</ref>
<ref id="B107">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yahiro</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Akazawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nakano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hisatune</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Isomoto</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>
<italic>Helicobacter pylori</italic> VacA induces apoptosis by accumulation of connexin 43 in autophagic vesicles via a Rac1/ERK-dependent pathway</article-title>. <source>Cell. Death Discov.</source> <volume>1</volume>, <fpage>15035</fpage>. <pub-id pub-id-type="doi">10.1038/cddiscovery.2015.35</pub-id>
</citation>
</ref>
<ref id="B108">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yasumoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mukaida</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Murakami</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Matsushima</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kB-like binding sites of the interleukin 8 gene</article-title>. <source>J. Biol. Chem.</source> <volume>267</volume> (<issue>31</issue>), <fpage>22506</fpage>&#x2013;<lpage>22511</lpage>. <pub-id pub-id-type="doi">10.1016/s0021-9258(18)41701-2</pub-id>
</citation>
</ref>
<ref id="B109">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>M. Z.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Bcl-2/Bcl-xl inhibitor APG-1252-M1 is a promising therapeutic strategy for gastric carcinoma</article-title>. <source>Cancer Med.</source> <volume>9</volume> (<issue>12</issue>), <fpage>4197</fpage>&#x2013;<lpage>4206</lpage>. <pub-id pub-id-type="doi">10.1002/cam4.3090</pub-id>
</citation>
</ref>
<ref id="B110">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Grabowska</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Whelband</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Argent</surname>
<given-names>R. H.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>
<italic>Helicobacter pylori</italic> potentiates epithelial:mesenchymal transition in gastric cancer: Links to soluble HB-egf, gastrin and matrix metalloproteinase-7</article-title>. <source>Gut</source> <volume>59</volume> (<issue>8</issue>), <fpage>1037</fpage>&#x2013;<lpage>1045</lpage>. <pub-id pub-id-type="doi">10.1136/gut.2009.199794</pub-id>
</citation>
</ref>
<ref id="B111">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoon</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S. G.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>B. K.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H. J.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>
<italic>Helicobacter pylori</italic> eradication downregulates cellular inhibitor of apoptosis protein 2 in gastric carcinogenesis</article-title>. <source>Gut Liver</source> <volume>11</volume> (<issue>1</issue>), <fpage>79</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.5009/gnl15585</pub-id>
</citation>
</ref>
<ref id="B112">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Pardoll</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Jove</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>STATs in cancer inflammation and immunity: A leading role for STAT3</article-title>. <source>Nat. Rev. Cancer</source> <volume>9</volume> (<issue>11</issue>), <fpage>798</fpage>&#x2013;<lpage>809</lpage>. <pub-id pub-id-type="doi">10.1038/nrc2734</pub-id>
</citation>
</ref>
<ref id="B113">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Involvement of NF-&#x3ba;B signaling pathway in the regulation of PRKAA1-mediated tumorigenesis in gastric cancer</article-title>. <source>Artif. Cells Nanomed Biotechnol.</source> <volume>47</volume> (<issue>1</issue>), <fpage>3677</fpage>&#x2013;<lpage>3686</lpage>. <pub-id pub-id-type="doi">10.1080/21691401.2019.1657876</pub-id>
</citation>
</ref>
<ref id="B114">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2022a</year>). <article-title>
<italic>H. pylori</italic> CagA activates the NLRP3 inflammasome to promote gastric cancer cell migration and invasion</article-title>. <source>Inflamm. Res.</source> <volume>71</volume> (<issue>1</issue>), <fpage>141</fpage>&#x2013;<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1007/s00011-021-01522-6</pub-id>
</citation>
</ref>
<ref id="B115">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Soutto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Bhat</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Eissmann</surname>
<given-names>M. F.</given-names>
</name>
<etal/>
</person-group> (<year>2022b</year>). <article-title>Induction of fibroblast growth factor receptor 4 by <italic>Helicobacter pylori</italic> via signal transducer and activator of transcription 3 with a feedforward activation loop involving steroid receptor coactivator signaling in gastric cancer</article-title>. <source>Gastroenterology</source>. <volume>163</volume>. <fpage>620</fpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2022.05.016</pub-id>
</citation>
</ref>
<ref id="B116">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Transformed immortalized gastric epithelial cells by virulence factor CagA of <italic>Helicobacter pylori</italic> through Erk mitogen-activated protein kinase pathway</article-title>. <source>Oncogene</source> <volume>24</volume> (<issue>24</issue>), <fpage>3886</fpage>&#x2013;<lpage>3895</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1208551</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>